61 – 70 of 81
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
Cardiovascular outcomes in antineutrophil cytoplasm antibody associated vasculitis (AAV)
(
- Contribution to journal › Published meeting abstract
- 2007
-
Mark
Sjukdomar i njurar och urinvägar
2007) p.303-303(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Development of comprehensive disease assessment in systemic vasculitis
(
- Contribution to journal › Article
-
Mark
På väg mot evidensbaserad terapi vid primär systemisk vaskulit. De senaste decenniernas framsteg har gett dagens patienter bättre läge
(
- Contribution to journal › Article
-
Mark
Randomized trial of plasma exchange or high-dosage Methylprednisolone as adjunctive therapy for severe renal vasculitis
(
- Contribution to journal › Article
- 2006
-
Mark
Increased neutrophil membrane expression and plasma level of proteinase 3 in systemic vasculitis are not a consequence of the - 564 A/G promotor polymorphism.
(
- Contribution to journal › Article
- 2004
-
Mark
Dialysis-linked complaints and burdens of illness on patient and spouse as predictors of survival in end-stage renal disease patients with home hemodialysis: a 10-year follow-up study
(
- Contribution to journal › Article
-
Mark
Evaluation of capture ELISA for detection of antineutrophil cytoplasmic antibodies directed against proteinase 3 in Wegener's granulomatosis: first results from a multicentre study
(
- Contribution to journal › Article
- 2003
-
Mark
A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies
(
- Contribution to journal › Article
-
Mark
High proteinase 3-anti-neutrophil cytoplasmic antibody (ANCA) level measured by the capture enzyme-linked immunosorbent assay method is associated with decreased patient survival in ANCA-associated vasculitis with renal involvement
(
- Contribution to journal › Article